Tetranuclear NiII-Mannich base complex with oxygenase, water splitting and ferromagnetic and antiferromagnetic coupling properties

A new Mannich base (2-(4-(2-hydroxy-3-methoxy-5-methylbenzyl)-piperazin-1-yl)methyl)-6-methoxy-4-ethylphenol (H2L) and its tetranuclear NiII complex [Ni4L2(μ1,1-Cl)2(H2O)4]Cl2 (compound 1) are characterised using single-crystal X-ray diffraction measurements. Compound 1 contains four different NiII centres in a rhombus-like structure. Two Ni atoms (Ni1 and Ni2) have a NiN2O4 coordination sphere, while the other two (Ni3 and Ni4) have a NiO4Cl2 coordination environment and Ni-Cl-Ni bridges connect them. Ni1 and Ni2 are linked to Ni3 and Ni4 by phenoxide bridges. Variable temperature magnetic susceptibility measurements of 1 indicate the presence of alternating antiferromagnetic coupling (J1 = -6.6(1) cm-1) through the phenoxide bridge along the sides of the rhombus and ferromagnetic coupling (J2 = 8.4(1) cm-1) through the double Cl bridge along the short diagonal of the rhombus with a zero-field splitting of |D| = 2.7(1) cm-1. Compound 1 shows oxidase (catecholase-like and phenoxazinone synthase-like) activity. The oxidation of 3,5-di-tert-butylcatechol (3,5-DTBC) gives 3,5-di-tert-butylquinone (3,5-DTBQ) and H2O2 and the oxidation of o-aminophenol (OAP) produces 2-aminophenoxazin-3-one (APX) and H2O with turnover numbers of 28.32 and 17.52 h-1, respectively, under aerobic conditions. A mechanism for the oxidase activity catalysed by compound 1 is proposed in line with ESI-mass spectrometry, EPR spectroscopy, and electrochemical data. The reaction involves the cleavage of the tetranuclear Ni4-core to form a mononuclear NiII complex in the presence of the substrate (3,5-DTBC/OAP). This NiII complex is reduced to NiI with the concomitant oxidation of the substrate (3,5-DTBQ/APX). Formation of a radical intermediate is confirmed using EPR. In the catecholase-like activity, O2 is reduced to H2O2 while in the phenoxazinone synthase-like activity O2 produces H2O. Compound 1 participated in oxygen evolution reaction (OER) and hydrogen evolution reaction (HER) in a strongly basic medium with an onset potential of 418 mV and a Tafel slope of 121 mV dec-1 for OER and an onset potential of 477 mV and Tafel slope of 146 mV dec-1 for HER.

The influence of thioether-substituted ligands in dicopper(II) complexes: Enhancing oxidation and biological activities

This paper describes the synthesis, structural analysis, as well as the magnetic and spectroscopic characterizations of three new dicopper(II) complexes with dinucleating phenol-based ligands containing different thioether donor substituents: aromatic (1), aliphatic (2) or thiophene (3). Temperature-dependent magnetometry reveals the presence of antiferromagnetic coupling for 1 and 3 (J = -2.27 cm-1 and -5.01 cm-1, respectively, H = -2JS1S2) and ferromagnetic coupling for 2 (J = 5.72 cm-1). Broken symmetry DFT calculations attribute this behavior to a major contribution from the dz2 orbitals for 1 and 3, and from the dx2-y2 orbitals for 2, along with the p orbitals of the oxygens. The bioinspired catalytic activities of these complexes related to catechol oxidase were studied using 3,5-di-tert-butylcatechol as substrate. The order of catalytic rates for the substrate oxidation follows the trend 1 > 2 > 3 with kcat of (90.79 ± 2.90) × 10-3 for 1, (64.21 ± 0.99) × 10-3 for 2 and (14.20 ± 0.32) × 10-3 s-1 for 3. The complexes also cleave DNA through an oxidative mechanism with minor-groove preference, as indicated by experimental and molecular docking assays. Antimicrobial potential of these highly active complexes has shown that 3 inhibits both Staphylococcus aureus bacterium and Epidermophyton floccosum fungus. Notably, the complexes were found to be nontoxic to normal cells but exhibited cytotoxicity against epidermoid carcinoma cells, surpassing the activity of the metallodrug cisplatin. This research shows the multifaceted properties of these complexes, making them promising candidates for various applications in catalysis, nucleic acids research, and antimicrobial activities.

Tetranuclear copper(II) complex of 2-hydroxy-N,N′-bis[1-(2-hydroxyphenyl)ethylidene]propane-1,3-diamine

In the title Schiff base tetra­nuclear copper(II) complex, two discrete environments are present in the structure: CuNO₄ and CuNO₃. Two copper(II) cations are situated in distorted square-pyramidal environment, while two copper(II) cations are located in a slightly square-planar geometry. One bridging acetate group acting in an η¹:η¹-μ₂-mode connects two copper(II) ions, while another bridging acetate group connects three copper(II) ions in an η¹:-η²–μ₃-mode.

The title mol­ecular structure, namely, (μ₃-acetato)(μ₂-acetato)­bis­(μ₃-1,3-bis­{[1-(2-oxidophen­yl)ethyl­idene]amino}­propan-2-olato)tetra­copper(II) monohydrate, [Cu₄(C₁₉H₁₉N₂O₃)₂(CH₃CO₂)₂]·H₂O, corresponds to a non-symmetric tetra­nuclear copper complex. The complex exhibits one ligand mol­ecule that connects two copper Cu^II metal centres via its ethano­lato oxygen anion acting in a μ₂-mode and one ligand mol­ecule that connects three copper Cu^II metal centres via its ethano­lato oxygen anion acting in a μ₃-mode. One bridging acetate group acting in an η¹:η¹-μ₂-mode connects two copper(II) ions while another bridging acetate group connects three copper(II) ions in an η¹:-η²-μ₃-mode. A chair-like Cu₃O₃ structure is generated in which the two CuO₄N units are connected by one μ₂-O ethano­late oxygen atom. These two units are connected respectively to the CuO₃N unit via one μ₃-O ethano­late oxygen atom and one μ₂-O atom from an acetate group. The μ₃-O atom also connects one of the CuO₄N units and the CuO₃N unit to another CuO₃N unit, which is out of the chair-like structure. Each of the two penta­coordinated Cu^II cations has a distorted NO₄ square-pyramidal environment. The geometry of each of the two CuNO₃ units is best described as a slightly square-planar environment. A series of intra­molecular O—H⋯O hydrogen bonds is observed. In the crystal, the units are connected by inter­molecular C—H⋯O and O—H⋯O hydrogen bonds, thus forming sheets parallel to the ac plane

Azide-mediated unusual in situ transformation of Mannich base to Schiff-Mannich base and isolation of their Cu(II) complexes: crystal structure, theoretical inspection and anticancer activities

A new "end-off" compartmental Mannich ligand (HL1) namely 3-((bis(2-methoxyethyl)amino)methyl)-5-bromo-2-hydroxybenzaldehyde containing two methoxyethyl pendant arms and one-CHO functionality has been synthesized through conventional C-C and C-N coupling reactions. On treatment with Cu(ClO₄)₂, HL1 yields a dinuclear μ-phenolatocopper(II) complex having the molecular formula [Cu₂(L¹)₂](ClO₄)₂(H₂O)_1.5 (1). Surprisingly, the ligand HL1 is radically transformed into a new asymmetric Schiff-Mannich base ligand (HLF) in the presence of NaN₃ and Cu(ClO₄)₂ forming a unique dinuclear centro-symmetric Cu(II) complex [Cu(L^F)]₂ (2) as evident from single-crystal X-ray diffraction (SCXRD) analysis. A probable mechanistic rationalization has been proposed on the basis of theoretical calculations, which suggests systematic fragmentation of HL1 in the presence of azide residue and re-condensation of the fragmented units to yield the final Cu-HL^F complex (2). SCXRD analysis portrays a large inter-metallic distance in complex 2 in comparison with complex 1 (5.493 vs. 2.989 Å, respectively) along with other distinct structural features. After physicochemical characterization both the complexes have been exploited to evaluate their possible anticancer proficiency on lung adenocarcinoma cell line (A549). Complex 1 distinctly impeded the proliferation of lung adenocarcinoma cells in a dose-dependent manner more efficiently than complex 2. Due to the behavior of complex 1 as potential therapeutics, cellular transformations of A549 cells have been systematically investigated. As evidenced from various in vitro experiments, the cell death mechanism triggered by complex 1 turned out to be apoptosis, as indicated by the DNA fragmentation, chromatin condensation, membrane blebbing and imbalanced cell cycle distribution as well as retard migration in A549 cells.